Nazione: Australia
Lingua: inglese
Fonte: Department of Health (Therapeutic Goods Administration)
thiamine hydrochloride, Quantity: 100 mg/mL; riboflavine sodium phosphate, Quantity: 2 mg/mL; nicotinamide, Quantity: 20 mg/mL; dexpanthenol, Quantity: 20 mg/mL; pyridoxine hydrochloride, Quantity: 40 mg/mL; cyanocobalamin, Quantity: 0.4 mg/mL
Orthomolecular Medisearch Laboratories Pty Ltd Trading As Biological Therapies
Cyanocobalamin,Dexpanthenol,Nicotinamide,pyridoxine hydrochloride,riboflavine sodium phosphate,Thiamine hydrochloride
Injection, solution
Excipient Ingredients: disodium edetate; benzyl alcohol; water for injections
Intramuscular
3 x 2.5mL, 5 x 2.5mL, 1 x 2.5mL, 6 x 2.5mL
(S4) Prescription Only Medicine
B vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. Oral administration of B vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. Specific indications include: 1. Rapid saturation of the B group vitamins. 2. When oral administration is not feasible or appropriate. 3. For alcoholic, debilitated and elderly patients when their diet is inadequate. 4. Beriberi and Wernicke's syndrome as a result of Vitamin B1 deficiency. 5. Pellagra as a result of Vitamin B3 deficiency. Patients with pellagra may have a concurrent deficiency of B1, B2, B6 and B12. 6. Peripheral neuritis caused by various B group deficiencies. 7. Carpal tunnel syndrome. 8. Pernicious anaemia as a result of in situ B12 deficiency. General indications include: 1. Angular stomatitis and glossitis have been shown in some instances to respond to t
Visual Identification: Amber coloured liquid; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 6 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
1991-10-08
BIOLOGICAL THERAPIES B-DOSE FORTE 2.5 ML INJECTION _VITAMIN B COMPLEX FOR INTRAMUSCULAR INJECTION _ CONSUMER MEDICINE INFORMATION _Biological Therapies B-Dose Forte 2.5 mL Injection Version ID: cmi19s1910 _ _page 1 of 3 _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Biological Therapies B-Dose Forte 2.5 mL Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of administering B-Dose Forte Injection against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT THE ADMINISTRATION OF THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BIOLOGICAL THERAPIES B-DOSE FORTE INJECTION IS USED FOR B-Dose Forte 2.5 mL Injection contains the Vitamins B1, B2, B3, B5, B6 and B12 as the following active ingredients: B1 - Thiamine hydrochloride, B2 - Riboflavine sodium phosphate, B3 - Nicotinamide, B5 - Dexpanthenol, B6 - Pyridoxine hydrochloride, B12 - Cyanocobalamin. These B vitamins are required by the body for normal metabolic processes in your cells, including the production of energy. Different metabolic processes need several of these B vitamins at the same time. Deficiencies of one, some or all of these vitamins in your cells can have serious consequences for your health. Vitamin B deficiencies: Vitamin B deficiencies may occur as a result of a diet deficient in B vitamins, malnutrition, or changes to the gastrointestinal tract which slow or prevent the absorption of B vitamins (e.g. abdominal surgery or some diseases of the gastrointestinal tract). A specific deficiency of vitamin B1 (thiamine) may cause the disease beriberi. A specific deficiency of vitamin B3 (niacin) may cause the disease pellagra. A specific deficiency of vitamin B12 (cobalamin) may cause the disease pernicious anaemia. Some of the B vitamins need other B vitamins to work properly. Your Leggi il documento completo
AUSTRALIAN PRODUCT INFORMATION BIOLOGICAL THERAPIES B-DOSE FORTE 2.5 ML INJECTION (THIAMINE HYDROCHLORIDE, RIBOFLAVINE SODIUM PHOSPHATE, NICOTINAMIDE, DEXPANTHENOL, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN) Biological Therapies Page 1 of 8 Version ID: pi19s1909 AUST R 22408 1 NAME OF THE MEDICINE Thiamine hydrochloride Riboflavine sodium phosphate Nicotinamide Dexpanthenol Pyridoxine hydrochloride Cyanocobalamin 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Biological Therapies B-Dose Forte 2.5 mL Injection is a B complex mixture of B1, B2, B3, B5, B6 and B12. Each vial contains a minimum of 2.5 mL of solution. 2.5 mL of this formulation contains: (B1) Thiamine hydrochloride 250 mg (B2) Riboflavine sodium phosphate 5 mg (B3) Nicotinamide 50 mg (B5) Dexpanthenol 50 mg (B6) Pyridoxine hydrochloride 100 mg (B12) Cyanocobalamin 1 mg For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Biological Therapies B-Dose Forte 2.5 mL Injection is a clear, amber colour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS B vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. Oral administration of B vitamins may be insufficient in: alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. SPECIFIC INDICATIONS INCLUDE: 1. Rapid saturation of the B group vitamins. 2. When oral administration is not feasible or appropriate. 3. For alcoholic, debilitated and elderly patients when their diet is inadequate. 4. Beriberi and Wernicke’s syndrome as a result of Vitamin B1 deficiency. 5. Pellagra as a result of Vitamin B3 deficiency. Patients with pellagra may have a concurrent deficiency of B1, B2, B6 and B12. 6. Peripheral neuritis caused by various B group deficiencies. 7. Carpal tunnel syndrome. 8. Pernicious anaemia as a result of in situ B12 deficiency. GENERAL INDICATIONS INCLUDE: 1. Angular stomatitis and glossitis have been show Leggi il documento completo